Group Testing Methodologies for Infectious Disease Screening
Summary
Group testing, also known as pooled testing, is a strategic framework in which specimens from multiple individuals are combined and analysed in a single assay. Originating with Dorfman’s two‐stage design in the 1940s, these methods have evolved to encompass multi‐stage algorithms, halving schemes and adaptive pooling protocols. Central to their appeal is the capacity to conserve reagents, reduce laboratory workload and expand testing coverage—advantages that are particularly salient during emergent outbreaks and in resource‐limited settings. Modern approaches integrate mathematical modelling of viral load kinetics, pooling dilution effects and assay performance to inform optimal pool sizes and testing schedules. Advances in molecular diagnostics, including high‐throughput PCR and multiplex assays, have further extended group testing’s applicability to simultaneous screening for multiple pathogens. Implementation ranges from population‐scale surveillance for low‐prevalence infections to rapid identification of hot‐spots in communities. By balancing cost savings against potential sensitivity losses, group testing methodologies continue to underpin efficient, scalable infectious disease screening on a global scale.
Research from Nature Portfolio
A recent study developed an open‐source framework to simulate and compare a wide array of pooling configurations for SARS-CoV-2 screening. Leveraging thousands of empirical viral load measurements, the investigators employed a hybrid in silico/in vitro approach to identify multi‐stage pooling strategies with group sizes exceeding 100. They demonstrated that carefully tuned algorithms can markedly boost the detection of asymptomatic spreaders while conserving testing resources. The work emphasises prevalence‐dependent optimisation and provides practical guidance for deploying large‐scale surveillance programmes under reagent‐constrained conditions.
Group Testing Methodologies for Infectious Disease Screening publication trend
The graph below shows the total number of articles in group testing methodologies for infectious disease screening across all publications each year (not limited to Nature Index journals).
Technical terms
Group testing: The process of pooling specimens from multiple individuals into a single test to increase efficiency and reduce costs.
Pooling dilution: The reduction in analyte concentration that occurs when positive specimens are combined with negative ones in a pool.
Viral load progression: The temporal pattern of pathogen concentration in an infected individual, often modelled to predict test sensitivity.
Multi‐stage pooling: A sequential testing design in which positive pools are subdivided and retested in successive rounds to identify infected individuals.
Multiplex assay: A diagnostic test capable of detecting multiple pathogens simultaneously from a single pooled sample.
Prevalence estimation: The statistical inference of the proportion of infected individuals in a population based on pooled testing outcomes.
References
- A methodology for deriving the sensitivity of pooled testing, based on viral load progression and pooling dilution. Journal of Translational Medicine (2019).
- Simulation of group testing scenarios can boost COVID-19 screening power. Scientific Reports (2022).
- Estimating the prevalence of two or more diseases using outcomes from multiplex group testing. Biometrical Journal (2023).
- Combining Biomarkers to Improve Diagnostic Accuracy in Detecting Diseases With Group‐Tested Data. Statistics in Medicine (2024).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Nature Index 2026 Regenerative medicine
Regenerative medicine has the potential to transform the treatment of chronic and life-threatening diseases. But major challenges remain, such as overcoming immune rejection and ensuring that new therapies are developed using more inclusive data sets. In this supplement, we explore the discoveries that are driving the field, the barriers that could limit its progress, and the teams and institutions that are making their mark.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.